[1]
“Logistic precautions in preparation and administration of allergen immunotherapy during the COVID-19 pandemic in Mexico”, Rev Alerg Mex, vol. 67, no. 2, pp. 199–201, Jun. 2020, doi: 10.29262/ram.v67i2.752.